Nabla Bio pursues genAI protein design with $26M in funding, three pharma partners
Announcing JAM-2: Drug-like antibodies straight from the computer
Technical ReportAnnouncing JAM-2: Drug-like antibodies straight from the computer
Technical ReportNabla Bio pursues genAI protein design with $26M in funding, three pharma partners